A Common Gym Supplement May Have a Second Life as a Depression Treatment

Creatine — the supplement stacked on shelves next to protein powder — is now being seriously examined as a potential tool against depression, and the science behind the idea is more grounded than it might sound. The brain is an energy-hungry organ, and researchers have long observed that people with depression show altered energy metabolism in neural tissue. Creatine's established role in replenishing cellular energy (ATP) makes it a biologically logical candidate for investigation, not a long shot. A newly published review analyzed five randomized clinical trials involving 238 participants total — the kind of controlled, peer-reviewed foundation that separates signal from noise. Results were mixed overall, but a clear pattern emerged: the two trials that showed meaningful symptom improvement both focused on women with major depressive disorder receiving creatine as an add-on to existing treatment. That specificity matters. It suggests the benefit may not be universal, but it may be real and targetable. The mixed results across the five trials are not discouraging — they're informative. Science rarely delivers clean answers on the first pass, and 238 participants across five trials is a starting point, not a verdict. What the research community now has is a refined hypothesis: creatine supplementation alongside standard care may offer additional relief for a specific population, with a safety profile already well-documented from decades of athletic use. For the roughly 280 million people worldwide living with depression — many of whom find partial or no relief from existing treatments — every legitimate new avenue deserves rigorous pursuit. Creatine is inexpensive, widely available, and well-tolerated. If further research confirms and refines these early signals, the implications for accessible mental health support could be significant. The work continues, and that itself is worth noting.